These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 10420523)

  • 1. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
    Rosen H
    Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
    Bösing NM; Heise JW; Röher HD
    Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].
    Ausch C; Rosen HR; Schiessel R
    Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is neoadjuvant therapy for locally advanced stomach carcinoma standard?].
    Ajani JA
    Chirurg; 2002 Apr; 73(4):312-5. PubMed ID: 12063914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
    Kretzschmar A; Schlag PM
    Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of advanced stomach carcinoma. Current study concepts].
    Kuhn R; Ridwelski K
    Zentralbl Chir; 2000; 125 Suppl 2():176-81. PubMed ID: 11190641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative (neoadjuvant) chemotherapy in multimodality treatment concept of stomach carcinoma].
    Meyer HJ; Jähne J; Wilke H; Pichlmayr R
    Zentralbl Chir; 1995; 120(2):128-34. PubMed ID: 7709664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
    Lygidakis NJ; Sgourakis G; Aphinives P
    Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stomach cancer: multimodality therapy--reliable and new developments].
    Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1992; ():147-51. PubMed ID: 1493264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypothetical and reliable aspects of pre-, intra- and postoperative adjuvant therapy of stomach carcinoma].
    Meyer HJ; Opitz GJ; Jähne J; Wilke H
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():312-7. PubMed ID: 9931631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The German EORTC Study of neoadjuvant therapy of stomach carcinoma].
    Siewert JR; Schuhmacher C; Fink U
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():717-9. PubMed ID: 9931709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.
    Briasoulis E; Liakakos T; Dova L; Fatouros M; Tsekeris P; Roukos DH; Kappas AM
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):931-9. PubMed ID: 16761937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of neoadjuvant chemotherapy for gastric cancer].
    Fujii M; Kochi M; Mochizuki F
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2028-32. PubMed ID: 11103233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of immunochemo-surgery for gastric carcinoma.
    Kim JP; Yu HJ; Lee JH
    Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.